JAAD case reports 2024 Nov 26
Topical ruxolitinib for treatment-induced vitiligo in a patient with metastatic melanoma.
Related Questions
Do you hold ICI, prescribe steroids, or refer to dermatology, and does your approach vary between curative, adjuvant, or metastatic settings?
New answer by Medical Oncologist at IHA Hem Onc Consult (September 18, 2025)
I refer to dermatology when the vitiligo is extensive, causes discomfort due to the site of involvement (face), or is associated with significant pruritus. It is worth noting ...